ENTRY       D11260                      Drug
NAME        Carotuximab (USAN/INN)
FORMULA     C6420H9922N1718O2010S46
EXACT_MASS  144717.4148
MOL_WEIGHT  144806.7693
SEQUENCE    (Heavy chain)
            EVKLEESGGG LVQPGGSMKL SCAASGFTFS DAWMDWVRQS PEKGLEWVAE IRSKASNHAT
            YYAESVKGRF TISRDDSKSS VYLQMNSLRA EDTGIYYCTR WRRFFDSWGQ GTTLTVSSAS
            TKGPSVFPLA PSSKSTSGGT AALGCLVKDY FPEPVTVSWN SGALTSGVHT FPAVLQSSGL
            YSLSSVVTVP SSSLGTQTYI CNVNHKPSNT KVDKKVEPKS CDKTHTCPPC PAPELLGGPS
            VFLFPPKPKD TLMISRTPEV TCVVVDVSHE DPEVKFNWYV DGVEVHNAKT KPREEQYNST
            YRVVSVLTVL HQDWLNGKEY KCKVSNKALP APIEKTISKA KGQPREPQVY TLPPSRDELT
            KNQVSLTCLV KGFYPSDIAV EWESNGQPEN NYKTTPPVLD SDGSFFLYSK LTVDKSRWQQ
            GNVFSCSVMH EALHNHYTQK SLSLSPGK
            (Light chain)
            QIVLSQSPAI LSASPGEKVT MTCRASSSVS YMHWYQQKPG SSPKPWIYAT SNLASGVPVR
            FSGSGSGTSY SLTISRVEAE DAATYYCQQW SSNPLTFGAG TKLELKRTVA APSVFIFPPS
            DEQLKSGTAS VVCLLNNFYP REAKVQWKVD NALQSGNSQE SVTEQDSKDS TYSLSSTLTL
            SKADYEKHKV YACEVTHQGL SSPVTKSFNR GEC
            (Disulfide bridge: H22-H98, H145-H201, H221-L213, H227-H'227, H230-H'230, H2620H322, H368-H426, H'22-H'98, H'145-L'213, H'262-H'322, H'368-H'426, L23-L87, L133-L193, L'23-L'87, L'133-L'193)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-endoglin antibody
  TYPE      Monoclonal antibody
TARGET      ENG (CD105) [HSA:2022] [KO:K06526]
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Other cell surface molecules
               CD molecules
                ENG (CD105)
                 D11260  Carotuximab (USAN/INN)
DBLINKS     CAS: 1268714-50-6
            PubChem: 384585238
///
